Onconetix, Inc. — Director's Dealing 2024

Sep 26, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2024-09-24

Reporting Person: Bruhlmann Christian (Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-24	Common Stock	A	428010	—	Acquired	433910	Direct

Footnotes

F1: Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock ("Preferred Shares") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares.